John (jp) Guilinger PhD

JP is a leading innovator in the DNA-encoded library (DEL) field. As a part of X-Chem’s scientific team, JP has helped develop X-Chem into a world-leading drug discovery engine with first-rate DEL capabilities serving the biopharma industry. JP has been an integral project team member, contributing to the execution of >100 DEL projects with collaborators. Under JP’s scientific leadership, X-Chem has developed and operationalized advances in DEL screens for covalent irreversible inhibitors and screening targets in cellular lysate, among other advancements.

Before joining X-Chem, JP was a graduate student at Harvard University in David Liu’s group, where he led the development and studies of genome editing technologies, including CRISPR-Cas9. JP is a thought leader in the DEL space, with key DEL publications to his name. He received his BS in biochemistry from Brandeis University and holds a Ph.D. in molecular and cellular biology from Harvard University.